A detailed history of Northwestern Mutual Wealth Management CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 408 shares of UTHR stock, worth $147,234. This represents 0.0% of its overall portfolio holdings.

Number of Shares
408
Previous 289 41.18%
Holding current value
$147,234
Previous $92,000 58.7%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $37,013 - $43,262
119 Added 41.18%
408 $146,000
Q2 2024

Aug 15, 2024

SELL
$228.26 - $319.04 $6,163 - $8,614
-27 Reduced 8.54%
289 $92,000
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $11,802 - $13,972
56 Added 21.54%
316 $72,000
Q4 2023

Feb 13, 2024

SELL
$214.88 - $256.94 $16,760 - $20,041
-78 Reduced 23.08%
260 $57,000
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $30,078 - $35,250
142 Added 72.45%
338 $76,000
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $50,066 - $56,849
-244 Reduced 55.45%
196 $43,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $51,969 - $67,385
244 Added 124.49%
440 $98,000
Q4 2022

Feb 21, 2023

BUY
$205.95 - $280.43 $13,386 - $18,227
65 Added 49.62%
196 $54,000
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $5,082 - $6,104
-25 Reduced 16.03%
131 $27,000
Q2 2022

Aug 04, 2022

BUY
$174.81 - $241.14 $2,272 - $3,134
13 Added 9.09%
156 $37,000
Q1 2022

May 09, 2022

SELL
$166.16 - $213.96 $332 - $427
-2 Reduced 1.38%
143 $26,000
Q4 2021

Feb 03, 2022

BUY
$184.32 - $216.08 $368 - $432
2 Added 1.4%
145 $31,000
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $539 - $644
3 Added 2.14%
143 $26,000
Q2 2021

Aug 13, 2021

BUY
$170.47 - $211.93 $5,114 - $6,357
30 Added 27.27%
140 $25,000
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $10,187 - $15,179
-100 Reduced 47.62%
110 $17,000
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $8,491 - $10,296
85 Added 68.0%
210 $21,000
Q1 2020

May 08, 2020

SELL
$79.39 - $115.35 $2,064 - $2,999
-26 Reduced 17.22%
125 $11,000
Q3 2019

Nov 12, 2019

SELL
$74.85 - $85.99 $748 - $859
-10 Reduced 6.21%
151 $12,000
Q2 2019

Aug 12, 2019

SELL
$76.06 - $120.81 $4,943 - $7,852
-65 Reduced 28.76%
161 $13,000
Q1 2019

May 10, 2019

BUY
$107.15 - $126.84 $5,357 - $6,342
50 Added 28.41%
226 $27,000
Q4 2018

Feb 12, 2019

SELL
$101.4 - $128.73 $2,332 - $2,960
-23 Reduced 11.56%
176 $19,000
Q2 2018

Aug 10, 2018

BUY
$101.14 - $118.31 $4,146 - $4,850
41 Added 25.95%
199 $22,000
Q1 2018

May 14, 2018

SELL
$107.21 - $151.94 $964 - $1,367
-9 Reduced 5.39%
158 $17,000
Q4 2017

Jan 31, 2018

SELL
$118.58 - $151.28 $1,067 - $1,361
-9 Reduced 5.11%
167 $24,000
Q3 2017

Nov 07, 2017

BUY
$114.6 - $136.81 $114 - $136
1 Added 0.57%
176 $21,000
Q2 2017

Aug 10, 2017

BUY
N/A
175
175 $22,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.